In focus · trending topic

peptide hormone receptors

4 stories · following the connections

Crinetics Pharmaceuticals Completes $63.5 Million Series B Financing

By Nasdaq OMXMar 13, 2018, 6:00 PM UTC

Crinetics Pharmaceuticals Appoints Marc Wilson as Chief Financial Officer

By Nasdaq OMXJan 4, 2018, 2:01 PM UTC

Crinetics Pharmaceuticals to Present at J.P. Morgan Healthcare Conference

By Nasdaq OMXJan 2, 2018, 2:01 PM UTC

Crinetics Pharmaceuticals Initiates Phase 1 Study of Lead Candidate CRN00808 for Acromegaly

By Nasdaq OMXOct 26, 2017, 2:30 PM UTC